Related Experiment Video
Updated: Aug 4, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
A technique for accurate use of CD4+ cell counts
K Vedhara1, K H Nott, S M Richards
1Department of Medicine, University of Wales College of Medicine, Cardiff, UK.
Insights
A statistical test improves CD4+ cell count reliability for tracking HIV progression. This method enhances accuracy for both living and deceased patients, aiding clinical and research use.
Area of Science:
- Immunology
- Virology
- Biostatistics
Background:
- CD4+ cell counts are crucial for monitoring HIV infection progression.
- Concerns exist regarding the reliability of CD4+ cell counts as a sole indicator.
- Accurate monitoring is vital for both clinical management and research endeavors.
Purpose of the Study:
- To evaluate a statistical method for enhancing the accuracy of CD4+ cell count interpretation.
- To determine if this method improves the reliability of CD4+ cell counts in assessing HIV progression.
Main Methods:
- Collected CD4+ cell count data from deceased (N=60) and living (N=100) HIV-positive gay men.
- Calculated Pearson's product moment correlation coefficients for individuals to assess CD4+ count association with time since diagnosis.
- Defined reliability based on correlation coefficients of 0.7 or greater.
Main Results:
- Approximately 50% of individuals in both cohorts achieved correlations of 0.7 or higher.
- For these individuals, CD4+ cell counts were considered reliable indicators of disease progression.
- The statistical technique demonstrated effectiveness with both complete and partial CD4+ data.
Conclusions:
- The proposed statistical test significantly enhances the precision of CD4+ cell count utilization.
- This method offers a reliable approach to monitoring HIV progression using CD4+ cell counts.
- The technique is applicable across diverse patient data availability, including deceased and living cohorts.
Abstract:
Despite uncertainty over their reliability, CD4+ cell counts are used extensively in both clinical and research settings to document progression in HIV infection. We examined, therefore, whether the performance of a simple statistical test would facilitate greater accuracy in the use of this marker. CD4+ cell count data were collected from a cohort of deceased (N = 60) and living HIV-positive gay men (N = 100). Pearson's product moment correlation coefficients were calculated for each individual in order to examine the association between CD4+ counts and time since diagnosis. Correlations of 0.7 or greater were obtained in approximately 50 percent of cases in each cohort. For these individuals, CD4+ cell counts were deemed to be a reliable indicator of rate of progression. The results suggest that the proposed technique ensures greater precision in the use of CD4+ cell counts and that the technique cna be used in individuals with either complete (deceased patients) or partial (living patients) CD4+ data.
